1.Research on homology and cross reaction characteristics of human papillomavirus L2 N-terminal protein
Lingling LI ; Pengyun ZHAO ; Jia WANG ; Zhuha ZHOU ; Shanli ZHU ; Xiangyang XUE ; Lifang ZHANG
Chinese Journal of Microbiology and Immunology 2010;30(9):848-852
Objective To research the homology and cross reaction characteristics of human papillomavirus(HPV)16 type L2 N-terminal(1-200)protein in clinical common HPV infection types.Methods The amino acid sequences of the common HPV infection types(6,11,16,18 ,etc.)were blasted and it was found that 1-200 N-terminal sequence of L2 protein was highly homologous.The gene of HPV16 L2(1-200)was amplificated from tissue sample of cervical cancer patient and inserted into the prokaryotic expression vector PGEX-4T-1 to construct the recombinant plasmid PGEX-4T-1-HPV16 L2(1-200).After sequencing identification,the recombinant plasmid was tranformed into E.coli BL21(DE3).Induced by IPTG,the fusion protein containing HPV16 L2(1-200)was expressed and analyzed by both SDS-PAGE and Western blot.Furthermore,the specific binding capacity of the fusion protein to the HPV 6,11,16 and 18 DNA positive patient serums were analyzed by Western blot.The fusion protein was purified with Ni-NTA Agarose Kit and coated with ELISA reaction plates.The specific serum IgG of 98 condyloma acuminatum patients,135 cervix cancer patients and 96 healthy control subjects were detected respectively by indirect ELISA.Results After comparing the amino acid sequences of the common HPV infection types(HPV6,11,16,18,etc.),We found that the homology of HPV L2(1-200)reached 52.7%-74.3%.The recombinant plasmid PGEX-4T-1-HPV 16 L2(1-200)was constructed successfully.Highly expressed HPV16 L2(1-200)fusion protein was obtained and the expression level was account for up to about 22.6% of total bacterial protein.The relative molecular mass(Mr)of the fusion protein is about 49×103,which matches up to the expected Mr Meanwhile,the serums of HPV 6,11,16,18 DNA positive patients were used as the first antibody and the specific band was detected respectively at about 49 × 103 by Western blot.Indirect ELISA showed that the A490 values of the specific IgG of condyloma acuminatum group,cervical cancer group and healthy control subjects were 0.753 ± 0.262,0.756 ± 0.274 and 0.178 ± 0.157 with the positive rate were 89.8%,88.9% and 9.4% respectively.There was no significance of the specific IgG between condyloma acuminatum group and cervical cancer group(P>0.05),but it was significant among the three groups(P<0.001).Conclusion The N-terminal 1-200 amino acids of HPV L2 has high homology and there exits cross reaction among the most common HPV infection types.
2.Effects and mechanisms of a novel chalcone analogue-H175 on inducing colon cancer cells' apoptosis
Yusheng SUN ; Jun FANG ; Jinji JIN ; Lijun TAO ; Zhuha ZHOU ; Guanbao ZHU
Chinese Journal of General Surgery 2015;30(6):466-470
Objective To investigate the anti-tumor activity of a novel chalcone analogue-H175.Methods We synthesized chalcone analogues and further tested the cytotoxicity on colon cancer cell line (CT26) through MTT method,and identified H175 with powerful biological activity.Flow cytometry was used to assay the ability of H175 to induce CT26's apoptosis and inhibit its cell cycle.Western blot was used to detect the effect of H175 on ATF4 and CHOP expression in CT26.After knockdown CHOP by siRNA technology,further investigate the influence of H175 on cell's apoptosis through immunofluorescence (IF) and FCM.Results H175 inhibits the proliferation of CT26 (ICs0 =1.9 μmol/L),by inducing CT26's apoptosis inhibiting its cell cycle,on a dose-dependent manner of key protein CHOP of endocytoplasmic reticulum stress (ERS) signal path.siRNA technology confirmed H175 induce apoptosis by stimulating the CHOP over-expression.Conclusions Novel chalcone analogue-H175 show inhibitory effects on the proliferation of CT26 by activating the ERS signal path's key protein CHOP.
3.Targeting BMI-1-mediated epithelial-mesenchymal transition to inhibit colorectal cancer liver metastasis.
Zhiyao XU ; Zhuha ZHOU ; Jing ZHANG ; Feichao XUAN ; Mengjing FAN ; Difan ZHOU ; Zhenyu LIUYANG ; Ximei MA ; Yiyang HONG ; Yihong WANG ; Sherven SHARMA ; Qinghua DONG ; Guanyu WANG
Acta Pharmaceutica Sinica B 2021;11(5):1274-1285
Liver is the most common metastatic site for colorectal cancer (CRC), there is no satisfied approach to treat CRC liver metastasis (CRCLM). Here, we investigated the role of a polycomb protein BMI-1 in CRCLM. Immunohistochemical analysis showed that BMI-1 expression in liver metastases was upregulated and associated with T4 stage, invasion depth and right-sided primary tumor. Knockdown